Usana Health Sciences (USNA) Enterprise Value (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Enterprise Value data on file, last reported at -$111.5 million in Q2 2026.

• On a quarterly basis, Enterprise Value rose 11.14% year-over-year to -$111.5 million in Q2 2026; TTM through Apr 2026 was -$111.5 million, a 11.14% increase from a year earlier, with the FY2026 full-year figure at -$105.2 million, up 17.51% from the prior year.
• Enterprise Value for Q2 2026 stood at -$111.5 million, down from -$105.2 million in the prior quarter.
• Over the last five years, Enterprise Value for USNA reached as high as -$91.9 million in Q3 2025 and fell as low as -$364.9 million in Q3 2024.
• Historically, Enterprise Value has averaged -$231.1 million across 5 years, with a median of -$243.4 million in 2022.
• Across the five-year window, Enterprise Value slumped 30.3% in 2023 and jumped 74.82% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$288.4 million in 2022, then decreased by 14.56% to -$330.4 million in 2023, then soared by 61.4% to -$127.5 million in 2024, then grew by 27.97% to -$91.9 million in 2025, then fell by 21.38% to -$111.5 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$111.5 million in Q2 2026, -$105.2 million in Q1 2026, and -$91.9 million in Q3 2025.